A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The purpose of this study is to evaluate the clinical and endoscopic efficacy of guselkumab in pediatric participants with Crohn\'s Disease (CD) at the end of maintenance therapy (Week 52) among participants who were in clinical response to guselkumab at Week 12.
Epistemonikos ID: f552000269e52bf16b38775f898e3676b47b1f8c
First added on: May 15, 2024